Early measurement of interleukin-10 predicts the absence of CT scan lesions in mild traumatic brain injury

Cerebrospinal Fluid Chemokine (C-C Motif) Ligand 2 Is an Early-Response Biomarker for Blast-Overpressure-Wave–Induced Neurotrauma in Rats

(2017) Ying Wang et al.   JOURNAL OF NEUROTRAUMA

H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

(2017) Linnéa Lagerstedt et al.   PLoS One

Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury

(2016) Robert D. Welch et al.   JOURNAL OF NEUROTRAUMA

Blood biomarkers for brain injury: What are we measuring?

(2016) Keisuke Kawata et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Epidemiology of traumatic brain injury in Europe

(2015) Wouter Peeters et al.   ACTA NEUROCHIRURGICA

Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets

(2015) David J Graber et al.   Journal of Neuroinflammation

Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell–cell communication by chemokines

(2015) Stefka Gyoneva et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

(2015) Linda Papa et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

GFAP Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography in Trauma Patients with Mild Traumatic Brain Injury and Those with Extracranial Lesions

(2014) Linda Papa et al.   JOURNAL OF NEUROTRAUMA

Serum Biomarkers for Traumatic Brain Injury

(2014) Miriam D. Neher et al.   SOUTHERN MEDICAL JOURNAL

Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date

(2014) Antonino Tuttolomondo et al.   Drug Design Development and Therapy

Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update

(2013) Johan Undén et al.   BMC Medicine

Chemokine CCL2 Induces Apoptosis in Cortex Following Traumatic Brain Injury

(2013) Su Liu et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Screening of Biochemical and Molecular Mechanisms of Secondary Injury and Repair in the Brain after Experimental Blast-Induced Traumatic Brain Injury in Rats

(2013) Patrick M. Kochanek et al.   JOURNAL OF NEUROTRAUMA

GFAP-BDP as an Acute Diagnostic Marker in Traumatic Brain Injury: Results from the Prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study

(2013) David O. Okonkwo et al.   JOURNAL OF NEUROTRAUMA

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases

(2013) Christoph A. Mayer et al.   PLoS One

The Role of Markers of Inflammation in Traumatic Brain Injury

(2013) Thomas Woodcock et al.   Frontiers in Neurology

Rapid Analytical Methods for On-Site Triage for Traumatic Brain Injury

(2012) Stella H. North et al.   Annual Review of Analytical Chemistry

Functions of S100 Proteins

(2012) R. Donato et al.   CURRENT MOLECULAR MEDICINE

Biomarkers for the Diagnosis and Prognosis of Mild Traumatic Brain Injury/Concussion

(2012) Cameron B. Jeter et al.   JOURNAL OF NEUROTRAUMA

Elevated Levels of Serum Glial Fibrillary Acidic Protein Breakdown Products in Mild and Moderate Traumatic Brain Injury Are Associated With Intracranial Lesions and Neurosurgical Intervention

(2011) Linda Papa et al.   ANNALS OF EMERGENCY MEDICINE

Accuracy of the S100βprotein as a marker of brain damage in traumatic brain injury

(2011) J. J. Egea-Guerrero et al.   BRAIN INJURY